Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medpace Holdings, Inc. Director's Dealing 2022

May 24, 2022

30442_dirs_2022-05-24_5e1e9a60-287d-4440-9ea0-b91994c2a21f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2022-05-20

Reporting Person: Carley Brian T (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-05-20 STOCK OPTION (RIGHT TO BUY) $133.87 A 1903 Acquired 2029-05-20 Common Stock (1903) Direct

Footnotes

F1: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.